Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Aug 19;16(8):e0256716. doi: 10.1371/journal.pone.0256716

Correction: The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines

Su-Jin Moon, Jooyeon Jhun, Jaeyoon Ryu, Ji ye Kwon, Se-Young Kim, KyoungAh Jung, Mi-La Cho, Jun-Ki Min
PMCID: PMC8375999  PMID: 34411187

There are errors in the Funding statement. The correct Funding statement is as follows: This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C1851) and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2018R1A2B6007648 and 2020R1I1A1A01072520).

Reference

  • 1.Moon SJ, Jhun J, Ryu J, Kwon Jy, Kim SY, et al. (2021) The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines. PLOS ONE 16(2): e0245986. 10.1371/journal.pone.0245986 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES